Fairvalue-Calculator Fairvalue-Calculator
EN DE

La Savonnerie De Nyons (MLSDN) Fair Value & Analysis

Consumer Defensive · FR · Market cap €7.0M

Price€28.16
Fair Value€41.46
Upside+47.2%
Quality86/100
Evidence: Medium Range €29.02 – €53.90

Fair value as of: Jun 24, 2026

Analysis

La Savonnerie De Nyons (MLSDN) currently trades at €28.16, while our model-based Fair Value estimate is €41.46 — implying the stock looks roughly 47.2% undervalued today. We read business quality at 86/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

La Savonnerie De Nyons manufactures and sells soaps and cosmetics in France. It also offers perfumed sachets, soap holders, magnets, and totes. The company was incorporated in 2012 and is based in Nyons, France.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is La Savonnerie De Nyons (MLSDN) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €41.46 versus a price of €28.16 — about +47% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MLSDN?
Our 21-model fair value for La Savonnerie De Nyons is €41.46 (as of Jun 24, 2026), built from audited fundamentals. The current price is €28.16.
What is the quality score of MLSDN?
La Savonnerie De Nyons has a Quality Score of 86/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.